[1] |
Gelfer Y, Wientroub S, Hughes K, et al. Congenital talipes equinovarus: a systematic review of relapse as a primary outcome of the Ponseti method[J]. Bone Joint J, 2019, 101-B (6): 639-645. DOI: 10.1302/0301-620X.101B6.BJJ-2018-1421.R1.
|
[2] |
Wang ZD, Yan N, Liu LY, et al. SOX9 overexpression plays a potential role in idiopathic congenital talipes equinovarus[J]. Mol Med Rep, 2013, 7(3): 821-825. DOI: 10.3892/mmr.2012.1245.
|
[3] |
王正东, 颜南, 刘丽英, 等. HOXD13调控SOX9基因可能参与先天足部软组织畸形的发生[J].中国临床解剖学杂志, 2020, 38(6): 691-696. DOI: 10.13418/j.issn.1001-165x.2020.06.013.
|
[4] |
Chu HX, Jones NM. Changes in Hypoxia-Iinducible Factor-1 (HIF-1) and regulatory prolyl hydroxylase (PHD) enzymes following hypoxic-ischemic injury in the neonatal rat[J]. Neurochem Res, 2016, 41(3): 515-522. DOI: 10.1007/s11064-015-1641-y.
|
[5] |
Mi DH, Fang HJ, Zheng GH, et al. DPP-4 inhibitors promote proliferation and migration of rat brain microvascular endothelial cells under hypoxic/high-glucose conditions, potentially through the SIRT1/HIF-1/VEGF pathway[J]. CNS Neurosci Ther, 2019, 25(3): 323-332. DOI: 10.1111/cns.13042.
|
[6] |
Zheng LL, Huang J, Su Y, et al. Vitexin ameliorates preeclampsia phenotypes by inhibiting TFPI-2 and HIF-1alpha/VEGF in a l-NAME induced rat model[J]. Drug Dev Res, 2019, 80(8): 1120-1127. DOI: 10.1002/ddr.21596.
|
[7] |
Zhang B, Zhao Q, Li YS, et al. Moxibustion alleviates intervertebral disc degeneration via activation of the HIF-1alpha/VEGF pathway in a rat model[J]. Am J Transl Res, 2019, 11(9): 6221-6231. PMID: 31632589.
|
[8] |
Li LH, Yin XJ, Ma N, et al. Desferrioxamine regulates HIF-1 alpha expression in neonatal rat brain after hypoxia-ischemia[J]. Am J Transl Res, 2014, 6(4): 377-383. PMID: 25075254.
|
[9] |
Xiang YX, Du PC, Zhang XM, et al. Acetylpuerarin inhibits oxygen-glucose deprivation-induced neuroinflammation of rat primary astrocytes via the suppression of HIF-1 signaling[J]. Exp Ther Med, 2018, 16(3): 2689-2695. DOI: 10.3892/etm.2018.6509.
|
[10] |
Li YC, Hichson JA, Ambrosi DJ, et al. ABT-165, a dual variable domain immunoglobulin (DVD-Ig) targeting DLL4 and VEGF, demonstrates Ssuperior efficacy and favorable safety profiles in preclinical models[J]. Mol Cancer Ther, 2018, 17(5): 1039-1050. DOI: 10.1158/1535-7163.MCT-17-0800.
|
[11] |
Lobov I, Mikhailova N. The role of Dll4/Notch signaling in normal and pathological ocular angiogenesis: Dll4 controls blood vessel sprouting and vessel remodeling in normal and pathological conditions[J]. J Ophthalmol, 2018, 2018: 3565292. DOI: 10.1155/2018/3565292.
|
[12] |
Wen ZK, Shen Y, Berry G, et al. The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway[J]. Sci Transl Med, 2017, 9(399): eaal3322. DOI: 10.1126/scitranslmed.aal3322.
|
[13] |
Lee D, Kim D, Choi YB, et al. Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis[J]. MAbs, 2016, 8(5): 892-904. DOI: 10.1080/19420862.2016.1171432.
|
[14] |
Polansky H, Schwab H. How a disruption of the competition between HIF-1 and p53 for limiting p300/CBP by latent viruses can cause disease[J]. Genes Cancer, 2018, 9(5-6): 153-154. DOI: 10.18632/genesandcancer.178.
|